Post-effective amendment to a registration statement that is not immediately effective upon filing

Consolidated Statements of Shareholders' Equity

v3.23.1
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Common Shares
Additional Paid-in Capital
Accumulated Deficit
Total
Balance (in Shares) at Dec. 31, 2020 24,883,024      
Balance at Dec. 31, 2020   $ 164,264 $ (69,014) $ 95,250
Founders earnout shares vested (in Shares) 570,212      
Issuance of common shares upon vesting of RSUs (in Shares) 268,895      
Exercise of warrants (in Shares) 122,639      
Exercise of warrants   1,410 $ 1,410
Stock option exercise (in Shares) 40,942     158,882
Stock option exercise   10 $ 10
Share-based compensation expense   11,451 11,451
Beneficial conversion feature of Convertible Note   4,748 $ 4,748
Conversions of Convertible Note to common shares (in Shares) 720,085     720,085
Conversions of Convertible Note to common shares   6,047 $ 6,047
Reclassification and other   (420) (420)
Net Loss   (45,726) (45,726)
Balance (in Shares) at Dec. 31, 2021 26,605,797      
Balance at Dec. 31, 2021   187,510 (114,740) 72,770
Issuance of common shares, gross   27,686   27,686
Issuance of common shares, gross (in Shares) 14,994,765      
Issuance of common shares upon vesting of RSUs (in Shares) 377,527      
Stock option exercise (in Shares) 151,694      
Stock option exercise   22   22
Share-based compensation expense   2,343 2,343
Equity issuance costs   (1,361)   (1,361)
Beneficial conversion feature of Convertible Note   1,750   $ 1,750
Conversions of Convertible Note to common shares (in Shares) 1,507,000     1,507,000
Conversions of Convertible Note to common shares   3,363   $ 3,363
Net Loss     (66,165) (66,165)
Balance (in Shares) at Dec. 31, 2022 43,636,783      
Balance at Dec. 31, 2022   $ 221,313 $ (180,905) $ 40,408